Corentec Co., Ltd. (KOSDAQ: 104540)

Market Cap	76.84B
Revenue (ttm)	97.28B
Net Income (ttm)	-1.17B
Shares Out	12.79M
EPS (ttm)	-92.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,392
Open	6,020.00
Previous Close	6,010.00
Day's Range	5,950.00 - 6,130.00
52-Week Range	5,950.00 - 13,140.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Corentec

Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems, such as Lospa IS systems; Coralis shoulder systems; and trauma systems, including LCfit HTO plate systems and Optirad volar plate system. Corentec Co....

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2000
• Employees: 205
• Stock Exchange: KOSDAQ
• Ticker Symbol: 104540

Financial Performance

In 2023, Corentec's revenue was 92.05 billion, an increase of 44.03% compared to the previous year's 63.91 billion. Earnings were 4.06 billion, an increase of 127.72%.